Smart buy for EXE

Article Excerpt

EXTENDICARE INC., $14.29, is a buy. The company’s (Toronto symbol EXE; TSINetwork Rating: Extra Risk) (www.extendicare.com; Shares o/s: 83.5 million; Market cap: $1.2 billion; Dividend yield: 3.5%) ParaMed unit provides nursing care and other forms of assistance to clients who remain in their own homes. ParaMed has now entered into an agreement to buy Closing the Gap Healthcare Group Inc. and certain affiliates. The purchase price is $75.5 million, plus an earnout tied to new business revenue. Founded in 1990, Closing the Gap is a leading provider of integrated home and community-based healthcare services in Ontario and Nova Scotia; it delivers adult and pediatric care services in patients’ homes and in community clinics. On a combined basis, Extendicare’s home health care segment service volumes for 2024 would have been approximately 12.1 million hours (10% higher). Extendicare is still a buy. buy…